ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ryvu Therapeutics Receives Orphan Drug Designation AML Treatment
April 01, 2020Ryvu Therapeutics announced the U.S. Food and Drug Administration (FDA) has granted an orphan drug designation (ODD) to Ryvu's SEL120, for the treatment of patients with acute myeloid leukemia (AML). -
Selvita Announces Presentations on CDK8 Inhibitor SEL120 at the 60th American Society of Hematology Annual Meeting
November 26, 2018Selvita, a clinical stage drug discovery and development company engaged in the research and development of novel cancer therapies, today announced that ....
Pharma Sources Insight January 2025
